参考文献: [1]Zhang Yian, Li Yuhua, Hu Kai, et al. HR001, a novel CD19-targeted CAR-T cell therapy for patients with relapsed/ refractory non-Hodgkin's lymphoma: primary results of a phase Ⅱ study (HRAIN01-NHL01-Ⅱ). 2024 AACR. Abstract CT244. [2]国家卫生健康委办公厅.淋巴瘤诊...
2024年AACR年会于4月5日~4月10日在美国圣地亚哥盛大召开,聚焦“激励科学 • 推动进步 • 革新诊疗”主题,吸引了来自世界各地近20000名专业人士出席,分享癌症和相关生物医学的最新进展。 随着创新实力的增强,国内众多企业登上AACR的舞台...
[11]Trastuzumab deruxtecan (T-DXd) in Chinese patients (pts) with previously treated HER2 mutant non-small cell lung cancer (NSCLC): primary analysis from the Phase 2 DESTINY-Lung05 (DL-05) trial. Abstract CT248...
第115届AACR年会于美国东部时间2024年4月5~10日在美国举行。免疫单药在微卫星稳定(MSS)型结直肠癌(CRC)中疗效欠佳。一项1/2期研究探索了PI3K抑制剂Copanlisib联合纳武利尤单抗治疗MSS型CRC的安全性和疗效,在部分患者中显示出持续缓解,并进行了生物标志物分析。 Clinical Trials Plenary Session Abstract#CT007 Phase...
链接:https://aacrjournals.org/cancerres/article/84/6_Supplement/1773/735532/Abstract-1773-Deciphering-the-roles-of-germline?searchresult=1 6.题目:Spatial-resolved single-cell analysis of the tumor microenvironment in Alaska Native colorectal cancer patients ...
参考文献:J. E. Medina, et al. Early detection of ovarian cancer using cell-free DNA fragmentomes and protein biomarkers. 2024 AACR, abstract 6086/12 (来源:《肿瘤瞭望》编辑部) 声明 凡署名原创的文章版权属《肿瘤瞭望》所有,欢迎分享、转载。本文仅供医疗卫生专业人士了解最新医药资讯参考使用,不代表本...
[1]Zhang Yian, Li Yuhua, Hu Kai, et al. HR001, a novel CD19-targeted CAR-T cell therapy for patients with relapsed/ refractory non-Hodgkin's lymphoma: primary results of a phase Ⅱ study (HRAIN01-NHL01-Ⅱ). 2024 AACR. Abstract CT244. ...
Session Date and Time: Monday Apr 8, 2024 9:00 AM - 12:30 PM Location: Poster Section 42 Poster Board Number: 23 Published Abstract Number: 2479 04 建立KRAS G12C突变脑转移模型,用于前临床评估针对KRAS G12C的靶向抗癌治疗 KRAS在癌症中是最常见的致癌基因之一,尤其在肺癌中。临床研究显示,约有...
IO Biotech (Nasdaq: IOBT) today announced that an abstract has been accepted for presentation at the American Association for Cancer Research Annual Meeting 2024 (AACR 2024), taking place April 5-10, 2024 in San Diego, CA.
Abstract Number:CT025 Date: Sunday, April 7, 2024 Time: 3:00 PM - 5:00 PM PST Posters Candidate: BNT116 Session Title:Phase I Clinical Trials Abstract Title: “Preliminary results from LuCa-MERIT-1, a first-in-human Phase I trial evaluating the...